Serial Sampling at Scale: Protecting Plasma Quality, Logistics & Biobanking Across Longitudinal ctDNA & MRD Timepoints
2:20 pm - Thursday 18th March 2027
- Maintaining consistent plasma collection and processing across every serial timepoint, so that quality does not drift between sites, visits or countries
- Coordinating global logistics and long-term biobanking so that longitudinal sample series stay complete, traceable and fit for retrospective ctDNA analysis
- Applying lessons from studies such as IMVIGOR-11, where serial sample operations underpinned the MRD readout, to growing pharma investment in MRD-guided development
